Digoxin & Cardiac Glycosides Toxicity
Comprehensive emergency evaluation and protocolized management of acute and chronic cardiac glycoside poisoning (digoxin, digitoxin, oleander, foxglove, lily of the valley): pathophysiology of sodium-potassium ATPase pump blockade, intracellular calcium overload, autonomic effects, pathognomonic electrocardiographic manifestations, severe hyperkalemia as a mortality marker, exact DigiFab (digoxin-specific antibody fragments) vial dosing formulas, and critical pitfalls regarding calcium administration.
Resuscitation Quick Actions • First 2 Minutes
DigiFab Acute Overdose
Unknown dose/arrest: 10–20 vials IV push; Known ingestion: Vials = [Ingested mg * 0.8 * 1000]/0.5 mg
DigiFab Chronic Toxicity
Unknown level: 3–6 vials IV over 30 min; Known level: Vials = [Digoxin level (ng/mL) * Weight (kg)]/100
Hyperkalemia Management
DigiFab is the primary treatment for hyperkalemia. Avoid IV calcium salts. Use insulin + dextrose, albuterol, and sodium bicarbonate cautiously while awaiting DigiFab
Target Serum Level
Therapeutic: 0.5–0.9 ng/mL (heart failure) or 0.8–2.0 ng/mL (AF rate control); Toxicity can occur at 'normal' levels in hypokalemia/hypomagnesemia
Pathognomonic Dysrhythmia
Bidirectional ventricular tachycardia, accelerated junctional rhythm with AF, paroxysmal atrial tachycardia (PAT) with 2:1 AV block
Salvador Dalí ST Changes
Scooped, sagging down-sloping ST depressions ('reverse checkmark') reflect digoxin effect, NOT necessarily toxicity
Bottom-Line Clinical Pearl
Digoxin toxicity presents differently in acute overdose (severe hyperkalemia, nausea/vomiting, AV block) versus chronic toxicity in elderly patients with renal failure (insidious weakness, confusion, xanthopsia/yellow-green halos, ventricular ectopy/bidirectional VT with normal or mildly elevated potassium). In acute poisoning, serum potassium correlates directly with mortality (K+ > 5.5 mEq/L indicates ~100% mortality without DigiFab). Never give IV calcium salts for hyperkalemia in suspected digoxin toxicity due to historical and biological risk of 'stone heart' tetanic arrest; administer DigiFab immediately.
Cardiac glycosides (digoxin, digitoxin, ouabain, and natural plant glycosides found in Nerium oleander, Digitalis purpurea [foxglove], Convallaria majalis [lily of the valley], and Bufo toad venom) selectively and reversibly inhibit the sarcolemmal Na+/K+-ATPase pump in myocardium and vascular smooth muscle.
Pump inhibition increases intracellular sodium, thereby attenuating or reversing the activity of the Na+/Ca2+ exchanger (NCX). The resulting accumulation of intracellular calcium enhances sarcoplasmic reticulum calcium storage and contractility (positive inotropy). However, toxic intracellular calcium overload triggers delayed afterdepolarizations (DADs), producing increased automaticity, premature ventricular contractions (PVCs), and ventricular tachyarrhythmias. Simultaneously, digoxin stimulates vagal (parasympathetic) tone at the SA and AV nodes while increasing sympathetic outflow from the central nervous system, leading to profound sinus bradycardia, sinus exit block, and high-grade AV nodal conduction block.
| Parameter | Acute Toxicity (Single Ingestion) | Chronic Toxicity (Accumulation in Renal Failure) |
|---|---|---|
| Patient Demographics | Younger patients, intentional overdose, pediatric exploratory ingestions | Elderly patients with congestive heart failure or atrial fibrillation on maintenance digoxin |
| Precipitating Triggers | Massive acute ingestive load | Acute kidney injury, dehydration, diuretic-induced hypokalemia, drug interactions (amiodarone, verapamil, clarithromycin) |
| Gastrointestinal Symptoms | Profound nausea, vomiting, diffuse cramping abdominal pain, retching within 1–2 hours | Mild anorexia, subtle weight loss, vague nausea, lethargy, generalized malaise over weeks |
| Visual & Neuro Disturbances | Rare acutely unless massive dose | Xanthopsia (yellow-green color halos), photophobia, scotomas, delirium, confusion, weakness, hallucinations |
| Potassium Status | Severe Hyperkalemia (K+ > 5.5 to 8.0 mEq/L) due to systemic Na+/K+-ATPase inhibition | Normokalemic or Hypokalemic (diuretic use worsens myocardial sensitivity to digoxin) |
| Serum Digoxin Levels | Profoundly elevated (> 4–10 ng/mL); levels taken < 6h post-ingestion reflect distribution phase, not tissue binding | Modestly elevated (2.0–4.0 ng/mL), or even high-normal (1.5–2.0 ng/mL) in hypokalemic/acidotic patients |
Digoxin can cause virtually any cardiac dysrhythmia except rapidly conducted atrial fibrillation with rapid ventricular response (due to its vagotonic AV nodal blockade). The presence of increased ventricular automaticity combined with impaired AV nodal conduction is classic for digoxin cardiotoxicity.
| ECG Finding | Diagnostic & Clinical Significance | Pathophysiologic Mechanism |
|---|---|---|
| Salvador Dalí ST Depression | Sagging, scooped down-sloping ST depression (resembling Dalí's mustache) with flat/inverted T waves; indicates digoxin effect, NOT toxicity | Altered ventricular repolarization kinetics under therapeutic pump inhibition |
| Premature Ventricular Contractions (PVCs) | Most common dysrhythmia; frequent unifocal or multifocal PVCs, ventricular bigeminy or trigeminy | Delayed afterdepolarizations (DADs) from sarcoplasmic reticulum calcium leaks |
| Bidirectional Ventricular Tachycardia | Virtually pathognomonic for digoxin toxicity (or catecholaminergic polymorphic VT); beat-to-beat alternating QRS frontal axis | Alternating intraventricular pacemaker foci firing in right and left bundle branches |
| Paroxysmal Atrial Tachycardia with Block | Atrial rate 150–200 bpm with 2:1 or variable AV block; strongly suggestive of toxicity | Enhanced atrial automaticity coupled with vagotonic AV nodal block |
| Regularized Atrial Fibrillation | AF with a completely regular ventricular rhythm (accelerated junctional rhythm or complete heart block with escape) | High-grade complete AV dissociation with an independent junctional or ventricular escape rhythm |
Digoxin-specific antibody antigen-binding fragments (DigiFab) bind free intravascular digoxin with an affinity 1,000 times greater than that of the Na+/K+-ATPase pump. Each 40 mg vial of DigiFab neutralizes approximately 0.5 mg of digoxin or digitoxin.
| Clinical Scenario | DigiFab Dosing Formulation | Administration Route & Goal |
|---|---|---|
| Cardiac Arrest or Peri-Arrest | Empiric 10 to 20 vials (400–800 mg) | IV push over 1–3 minutes. Can repeat with 10 additional vials if no ROSC in 15 minutes. |
| Acute Ingestion: Known Quantity | Vials = [Total Ingested mg 0.8 1000]/0.5 mg = (Ingested mg * 0.8)/0.5 | Administer half dose IV push, remaining half over 30 minutes in NSS. |
| Acute/Chronic: Known Serum Digoxin | Vials = [Serum Digoxin (ng/mL) * Body Weight (kg)]/100 | Infuse IV over 30 minutes (or IV push if hemodynamically unstable). |
| Empiric Adult Chronic Toxicity | 3 to 6 vials (120–240 mg) | Infuse IV over 30 minutes; monitor on continuous telemetry. |
| Empiric Pediatric Overdose | 1 to 2 vials (40–80 mg) | Reconstitute each vial in 4 mL sterile water; infuse over 30 minutes. |
Critical Pitfall / Contraindication
CRITICAL CONTRAINDICATION: Do NOT administer intravenous calcium chloride or calcium gluconate for hyperkalemia when digoxin toxicity is suspected. Sarcoplasmic reticulum calcium overload can precipitate irreversible myocardial hypercontraction and death ('stone heart' tetany). Treat hyperkalemia primarily with DigiFab, which reactivates the Na+/K+ pump and shifts potassium intracellularly within 15–30 minutes.
1. Airway & Resuscitation: Provide supplemental oxygen, continuous telemetry, and two large-bore IVs. Avoid electrical cardioversion if possible; shocks in digitalized myocardium can induce refractory ventricular fibrillation or asystole. If cardioversion is unavoidable for unstable VT/VF, start at lowest energy (25–50 J) and premedicate with DigiFab.
Test Your Digoxin & Cardiac Glycosides Toxicity Clinical Acumen
Directly launch an active-recall practice block from our 8,400+ validated COMLEX Level 1, 2-CE & 3 board question bank with complete explanations.
Related Emergency Protocols & Differentials
Cardiovascular Drug Toxicities & Salicylates
Overview of calcium channel, beta-blocker, and salicylate overdoses.
Open Protocol Related EM ProtocolToxicology: Toxidromes & Antidotes
Universal toxidromes and emergency antidotes.
Open Protocol Related EM ProtocolTachydysrhythmias & Cardioversion
Management of narrow and wide complex tachycardias.
Open Protocol